We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer to Enroll Children as Young as 12 in COVID-19 Trial
Pfizer to Enroll Children as Young as 12 in COVID-19 Trial
Pfizer said it will add participants as young as 12 to the global phase 3 trial of its COVID-19 vaccine candidate to glean more information on how the treatment affects different age groups.